Pharmaceutical intermediates
Calcitriol Intermediates
5 pharmaceutical intermediates for Calcitriol. Indication: Psoriasis; Postmenopausal osteoporosis; Renal insufficiency; Vitamin D deficiency.
About Calcitriol
- Originator
- Validus
- Indication
- Psoriasis; Postmenopausal osteoporosis; Renal insufficiency; Vitamin D deficiency
- Approved Date
- 08/17/1978
Available intermediates
5 intermediates currently listed for Calcitriol. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| Silane, [[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- (9CI) | 111594-58-2 | / | / |
| (S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol | 128387-35-9 | / | / |
| (5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate | 169900-32-7 | / | / |
| 5-{2-[1-(5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol | 73837-24-8 | / | / |
| 6-(4-{2-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-heptan-2-ol | 140710-96-9 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →